Literature DB >> 34270760

Commentary: Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases.

Issam A Awad1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34270760      PMCID： PMC8440064          DOI： 10.1093/neuros/nyab247

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   5.315


× No keyword cloud information.
  4 in total

1.  Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations.

Authors:  Jon T Willie; James G Malcolm; Matthew A Stern; Lindsay O Lowder; Stewart G Neill; Brian T Cabaniss; Daniel L Drane; Robert E Gross
Journal:  Epilepsia       Date:  2019-01-17       Impact factor: 5.864

2.  Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases.

Authors:  James G Malcolm; J Miller Douglas; Alex Greven; Christopher Rich; Reem A Dawoud; Ranliang Hu; Andrew Reisner; Daniel L Barrow; Robert E Gross; Jon T Willie
Journal:  Neurosurgery       Date:  2021-07-16       Impact factor: 4.654

3.  Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations.

Authors:  David Satzer; James X Tao; Naoum P Issa; Ziyi Chen; Shasha Wu; Sandra Rose; John Collins; Issam A Awad; Peter C Warnke
Journal:  Neurosurg Focus       Date:  2020-04-01       Impact factor: 4.047

Review 4.  Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel.

Authors:  Amy Akers; Rustam Al-Shahi Salman; Issam A Awad; Kristen Dahlem; Kelly Flemming; Blaine Hart; Helen Kim; Ignacio Jusue-Torres; Douglas Kondziolka; Cornelia Lee; Leslie Morrison; Daniele Rigamonti; Tania Rebeiz; Elisabeth Tournier-Lasserve; Darrel Waggoner; Kevin Whitehead
Journal:  Neurosurgery       Date:  2017-05-01       Impact factor: 4.654
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.